Process of making a compressed tablets containing valsartan and microcrystalline cellulose

Disclosed is a process of making a compressed tablet having 20 to 360 mg of valsartan in free form as the only active agent, which amounts to 20 to 65% by weight of valsartan; 31 to 65% by weight of microcrystalline cellulose; and optionally crospovidone (wherein the weight ratio of microcrystalline...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	BULLOCK, GILLIAN ROSEMARY, DE GASPARO, MARC, GANTER, SABINA MARIA
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!